To exploit the substantial international sales potential of the cardio vitamin supplements, Dr Nguyen made the decision to sell his Ho Chi Minh Medical Device company to IdsMED, a subsidiary of the Hong Kong based Li & Fung Group. In a multi million dollar deal, the sale proceeds were used to finance the expansion of the Australian operation, and to fund clinical trials and product development.
NQ Healthcare Australia has recently expanded its markets into Cambodia and Laos. In the next 2 years, the company will launch its cardio supplements into China and Japan using an online sales platform.
NQ Healthcare Australia PTY. LTD is “Good Manufacturing Practice” (GMP) accredited.
Our core product focus has been in the medical fields of cardiology and cardiovascular surgery. Our pharmacy division is at an embryonic, but growing stage and we expect to have some key product registrations in 2019. In addition, we are also expanding our cardiology product lines.
We view our manufacturers as partners. We are careful and deliberate in the development of these relationships to ensure the right fit for the market. Each manufacturer is internationally renowned, has advanced R&D and product development capabilities and provides a clear advantage in its product applications.
NQ Healthcare Australia PTY. LTD has a team of 5 members, including a business partnership development director, a national operation manager and 3 in-house sales representatives. We also have logistics, warehouse/distribution and finance teams to provide timely delivery and customer support. NQ Healthcare Australia will continue to build a team of high caliber technical and non-technical professionals to provide the best possible service to our customers.